Erosive Pustular Dermatosis and Amivantamab for Lung Cancer: A Case Report
Introduction: Amivantamab is a monoclonal antibody against EGFR and MET receptors, indications for certain types of non-small cell lung cancer. Due to its mechanisms, cutaneous adverse effects are frequent and numerous. Case Presentation: A 67-year-old woman with metastatic adenosquamous carcinoma,...
Saved in:
| Published in: | Case reports in dermatology Vol. 17; no. 1; pp. 263 - 267 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Switzerland
S. Karger AG
13.06.2025
|
| Subjects: | |
| ISSN: | 1662-6567, 1662-6567 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!